The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLIN.L Share News (CLIN)

  • There is currently no data for CLIN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Kibo invests in Eqtec project; Clinigen falls

Thu, 16th Sep 2021 10:55

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

----------

AIM - WINNERS

----------

Galileo Resources PLC, up 20% at 1.32 pence, 12-month range 0.61p-2.80p. The miner, with projects in Botswana, Zambia and South Africa, says all conditions for licence sale agreement with ASX-listed Sandfire Resources Ltd have been met. Completion of deal set for September 22. The deal, first announced in January, will see Sandfire pay USD1.5 million in cash for nine Kalahari copper belt licences.

----------

Kibo Energy PLC, up 16% at 0.26 pence, 12-month range 0.16p-0.56p. The Africa- and UK-focused energy company will acquire just under a 55% stake in the proposed Billingham waste gasification and power plant in Teesside, UK. Fellow AIM listing Eqtec PLC will retain just under over a 45% stake. Kibo's initial funding contribution will amount to GBP3 million. Eqtec shares were 2.4% lower.

----------

AIM - LOSERS

----------

Clinigen Group PLC, down 9.7% at 632.14 pence, 12-month range 554.00p-891.79p. Staffordshire-based pharmaceuticals and services provider lowers its earnings before interest, tax, depreciation and amortisation growth outlook for the new financial year. It now expects Ebitda growth between 5% and 10%. Clinigen anticipates lower sales of the Erwinase cancer treatment. Double-digit growth was previously expected. In the year ended June 30, revenue rose 12% to GBP523.6 million from GBP466.7 million. Pretax profit more than doubled to GBP51.8 million from GBP23.2 million.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
7 Jul 2021 09:43

BROKER RATINGS: Berenberg says buy Shaftesbury, Capital & Counties

BROKER RATINGS: Berenberg says buy Shaftesbury, Capital & Counties

Read more
30 Jun 2021 13:07

Clinigen to sell UK specials business for up to £7.8m

(Sharecast News) - Pharmaceutical company Clinigen has agreed the disposal of its non-core UK specials manufacturing and aseptic compounding business to Target Healthcare for up to £7.75m.

Read more
30 Jun 2021 10:59

Clinigen to sell non-core UK Specials business for GBP7.8 million

Clinigen to sell non-core UK Specials business for GBP7.8 million

Read more
18 Jun 2021 09:39

BROKER RATINGS: HSBC upgrades airlines Ryanair, Wizz and easyJet

BROKER RATINGS: HSBC upgrades airlines Ryanair, Wizz and easyJet

Read more
9 Jun 2021 12:10

LONDON MARKET MIDDAY: Hesitation before risk events; Clinigen down 25%

LONDON MARKET MIDDAY: Hesitation before risk events; Clinigen down 25%

Read more
9 Jun 2021 10:44

CORRECT: Clinigen slides 25% as Covid hits other hospital treatments

CORRECT: Clinigen slides 25% as Covid hits other hospital treatments

Read more
9 Jun 2021 10:37

AIM WINNERS & LOSERS: Clinigen shares dive as earnings outlook lowered

AIM WINNERS & LOSERS: Clinigen shares dive as earnings outlook lowered

Read more
9 Jun 2021 09:31

BROKER RATINGS: Smith & Nephew gets upgrade while M&G receives cut

BROKER RATINGS: Smith & Nephew gets upgrade while M&G receives cut

Read more
9 Jun 2021 09:21

TOP NEWS: Clinigen slides 20% as Covid hits other hospital treatments

TOP NEWS: Clinigen slides 20% as Covid hits other hospital treatments

Read more
9 Jun 2021 09:07

Clinigen FY underlying earnings impacted by decrease in products revenue

(Sharecast News) - Pharmaceutical firm Clinigen said on Wednesday that while net revenues were still expected to be in line with both guidance and expectations, full-year adjusted underlying earnings were now projected to be within the range of £114.0m and £117.0m due to a decrease in revenues from its products division.

Read more
9 Jun 2021 08:46

LONDON MARKET OPEN: Stocks hover with sights set on US inflation

LONDON MARKET OPEN: Stocks hover with sights set on US inflation

Read more
9 Jun 2021 07:46

LONDON MARKET PRE-OPEN: UK competition regulator probes BA and Ryanair

LONDON MARKET PRE-OPEN: UK competition regulator probes BA and Ryanair

Read more
6 Apr 2021 15:52

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more
6 Apr 2021 13:27

Tuesday broker round-up

(Sharecast News) - Touchstone Exploration: Canaccord downgrades to speculative buy with a target price of 140p.

Read more
6 Apr 2021 09:16

Clinigen to supply Erwinase in UK in "milestone" with PBL partnership

Clinigen to supply Erwinase in UK in "milestone" with PBL partnership

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.